|
Characteristics
|
NKILA relative expression N (%)
|
p
|
|---|
|
Low expression (53)
|
High expression (53)
|
|---|
|
Age (y)
| | | |
|
< 60
|
27 (48.2)
|
29 (51.8)
|
0.697
|
|
≥ 60
|
26 (52.0)
|
24 (48.0)
|
|
Gender
| | | |
|
Male
|
36 (49.3)
|
37 (50.7)
|
0.834
|
|
Female
|
17 (51.5)
|
16 (48.5)
|
|
Differentiated degree
| | | |
|
Well
|
1 (1.9)
|
5 (9.4)
|
0.212
|
|
Media
|
33 (62.3)
|
28 (52.8)
|
|
Poor
|
19 (35.8)
|
20 (37.7)
|
|
Pathological type
| | | |
|
Squamous carcinoma
|
26 (49.1)
|
27 (50.9)
|
0.846
|
|
Adenocarcinoma
|
27 (50.9)
|
26 (49.1)
|
|
Clinical stage
| | | |
|
I-II
|
25 (44.1)
|
34 (55.9)
|
0.048
*
|
|
III-IV
|
29 (57.4)
|
18 (42.6)
|
|
T stage
| | | |
|
I-II
|
36 (43.4)
|
47 (56.6)
|
0.010
*
|
|
III-IV
|
17 (73.9)
|
6 (16.1)
|
|
Tumor size
| | | |
|
< 3 cm
|
10 (32.3)
|
21 (67.7)
|
0.019
*
|
|
≥ 3 cm
|
43 (57.3)
|
32 (42.7)
|
|
Lymph node metastasis
| | | |
|
Negative
|
18 (34.6)
|
34 (63.4)
|
0.002
*
|
|
Positive
|
35 (64.8)
|
19 (35.2)
|
- *Bolded data indicates statistically significant differences
